These data suggest that the xenograft breast tumor growth enhanced by resistin-stimulated ADSCs was potentially associated with the increased expression of CXCL5 and mesenchymal markers, such as Slug, along with the activation of ERK pathway. The gene discussed is RETN; the disease is breast neoplasm.